Cargando…
Obatoclax Regulates the Proliferation and Fusion of Osteoclast Precursors through the Inhibition of ERK Activation by RANKL
Obatoclax, a pan-Bcl2 inhibitor, shows antitumor activities in various solid malignancies. Bcl2-deficient mice have shown the importance of Bcl2 in osteoclasts, as the bone mass of the mice was increased by the induced apoptosis of osteoclasts. Despite the importance of Bcl2, the effects of obatocla...
Autores principales: | Oh, Ju Hee, Lee, Jae Yoon, Park, Jin Hyeong, No, Jeong Hyeon, Lee, Na Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363729/ https://www.ncbi.nlm.nih.gov/pubmed/25666350 http://dx.doi.org/10.14348/molcells.2015.2340 |
Ejemplares similares
-
Spi-C positively regulates RANKL-mediated osteoclast differentiation and function
por: Go, Eun Mi, et al.
Publicado: (2020) -
Up-Regulation of RANK Expression via ERK1/2 by Insulin Contributes to the Enhancement of Osteoclast Differentiation
por: Oh, Ju Hee, et al.
Publicado: (2017) -
Serum amyloid A inhibits RANKL-induced osteoclast formation
por: Oh, Eunseo, et al.
Publicado: (2015) -
Barley Seedling Extracts Inhibit RANKL-Induced Differentiation, Fusion, and Maturation of Osteoclasts in the Early-to-Late Stages of Osteoclastogenesis
por: Choi, Sik-Won, et al.
Publicado: (2017) -
Carboxypeptidase E Is a Novel Modulator of RANKL-Induced Osteoclast Differentiation
por: Kim, Hyun-Ju, et al.
Publicado: (2014)